<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/nport" xmlns:com="http://www.sec.gov/edgar/common" xmlns:ncom="http://www.sec.gov/edgar/nportcommon" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sec.gov/edgar/nport eis_NPORT_Filer.xsd">
  <headerData>
    <submissionType>NPORT-P</submissionType>
    <isConfidential>false</isConfidential>
    <filerInfo>

      <filer>
        <issuerCredentials>
          <cik>0000872625</cik>
          <ccc>XXXXXXXX</ccc>
        </issuerCredentials>
      </filer>


      <seriesClassInfo>
        <seriesId>S000006882</seriesId>
        <classId>C000018631</classId>
        <classId>C000081539</classId>
        <classId>C000128862</classId>
        <classId>C000141458</classId>
      </seriesClassInfo>


    </filerInfo>
  </headerData>
  <formData>
    <genInfo>
      <regName>Franklin Strategic Series</regName>
      <regFileNumber>811-06243</regFileNumber>
      <regCik>0000872625</regCik>
      <regLei>549300NDWC0J6DXVSX36</regLei>
      <regStreet1>One Franklin Parkway</regStreet1>
      <regCity>San Mateo</regCity>
      <regStateConditional regCountry="US" regState="US-CA"/>
      <regZipOrPostalCode>94403-1906</regZipOrPostalCode>
      <regPhone>650-312-2000</regPhone>
      <seriesName>Franklin Biotechnology Discovery Fund</seriesName>
      <seriesId>S000006882</seriesId>
      <seriesLei>6N5133EDK315FXQQM036</seriesLei>
      <repPdEnd>2027-04-30</repPdEnd>
      <repPdDate>2026-07-31</repPdDate>
      <isFinalFiling>N</isFinalFiling>
    </genInfo>
    <fundInfo>
      <totAssets>1192074830.96</totAssets>
      <totLiabs>37827946.59</totLiabs>
      <netAssets>1154246884.37</netAssets>
      <assetsAttrMiscSec>0.00000000</assetsAttrMiscSec>
      <assetsInvested>0.00000000</assetsInvested>
      <amtPayOneYrBanksBorr>0.00000000</amtPayOneYrBanksBorr>
      <amtPayOneYrCtrldComp>0.00000000</amtPayOneYrCtrldComp>
      <amtPayOneYrOthAffil>0.00000000</amtPayOneYrOthAffil>
      <amtPayOneYrOther>0.00000000</amtPayOneYrOther>
      <amtPayAftOneYrBanksBorr>0.00000000</amtPayAftOneYrBanksBorr>
      <amtPayAftOneYrCtrldComp>0.00000000</amtPayAftOneYrCtrldComp>
      <amtPayAftOneYrOthAffil>0.00000000</amtPayAftOneYrOthAffil>
      <amtPayAftOneYrOther>0.00000000</amtPayAftOneYrOther>
      <delayDeliv>0.00000000</delayDeliv>
      <standByCommit>0.00000000</standByCommit>
      <liquidPref>0.00000000</liquidPref>
      <cshNotRptdInCorD>310802.11000000</cshNotRptdInCorD>
      <borrowers>
        <borrower aggrVal="1276016.00000000" lei="RUC0QBLBRPRCU4W1NE59" name="BMO Capital Markets"/>
        <borrower aggrVal="999174.00000000" lei="RCNB6OTYUAMMP879YW96" name="BNP Paribas Securities Corp"/>
        <borrower aggrVal="14230175.22000000" lei="AC28XWWI3WIBK2824319" name="Barclays Capital Inc."/>
        <borrower aggrVal="2112382.00000000" lei="549300HN4UKV1E2R3U73" name="BofA Securities, Inc."/>
        <borrower aggrVal="836439.64000000" lei="MBNUM2BPBDO7JBLYG310" name="Citigroup Global Markets Inc"/>
        <borrower aggrVal="322561.00000000" lei="MP6I5ZYZBEU3UXPYFY54" name="HSBC BANK PLC"/>
        <borrower aggrVal="1883272.80000000" lei="ZBUT11V806EZRVTWT807" name="J.P. Morgan Securities LLC"/>
        <borrower aggrVal="521680.00000000" lei="58PU97L1C0WSRCWADL48" name="Jefferies LLC"/>
        <borrower aggrVal="1093708.00000000" lei="9R7GPTSO7KV3UQJZQ078" name="Morgan Stanley &amp; Co. LLC"/>
        <borrower aggrVal="2860998.60000000" lei="549300JRHF1MHHWUAW04" name="National Financial Services LLC"/>
        <borrower aggrVal="951171.00000000" lei="549300F35UE0BOM1WJ55" name="SG Americas Securities, LLC"/>
        <borrower aggrVal="50970.00000000" lei="SUVUFHICNZMP2WKHG940" name="TD Securities (USA) LLC"/>
        <borrower aggrVal="8205476.00000000" lei="VYVVCKR63DVZZN70PB21" name="Wells Fargo Securities, LLC"/>
      </borrowers>
      <isNonCashCollateral>N</isNonCashCollateral>
      <returnInfo>
        <monthlyTotReturns>
          <monthlyTotReturn classId="C000018631" rtn1="3.13184000" rtn2="10.74303280" rtn3="-2.04632080"/>
          <monthlyTotReturn classId="C000081539" rtn1="3.15637100" rtn2="10.76607080" rtn3="-2.02528550"/>
          <monthlyTotReturn classId="C000128862" rtn1="3.16647620" rtn2="10.77148160" rtn3="-2.01627120"/>
          <monthlyTotReturn classId="C000141458" rtn1="3.06651740" rtn2="10.67374200" rtn3="-2.10736600"/>
        </monthlyTotReturns>
        <monthlyReturnCats>
          <commodityContracts>
            <mon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <forwardCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </forwardCategory>
            <futureCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </futureCategory>
            <optionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </optionCategory>
            <swaptionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swaptionCategory>
            <swapCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swapCategory>
            <warrantCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </warrantCategory>
            <otherCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </otherCategory>
          </commodityContracts>
          <creditContracts>
            <mon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <forwardCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </forwardCategory>
            <futureCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </futureCategory>
            <optionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </optionCategory>
            <swaptionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swaptionCategory>
            <swapCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swapCategory>
            <warrantCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </warrantCategory>
            <otherCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </otherCategory>
          </creditContracts>
          <equityContracts>
            <mon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <forwardCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </forwardCategory>
            <futureCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </futureCategory>
            <optionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </optionCategory>
            <swaptionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swaptionCategory>
            <swapCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swapCategory>
            <warrantCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </warrantCategory>
            <otherCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </otherCategory>
          </equityContracts>
          <foreignExchgContracts>
            <mon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <forwardCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </forwardCategory>
            <futureCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </futureCategory>
            <optionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </optionCategory>
            <swaptionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swaptionCategory>
            <swapCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swapCategory>
            <warrantCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </warrantCategory>
            <otherCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </otherCategory>
          </foreignExchgContracts>
          <interestRtContracts>
            <mon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <forwardCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </forwardCategory>
            <futureCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </futureCategory>
            <optionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </optionCategory>
            <swaptionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swaptionCategory>
            <swapCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swapCategory>
            <warrantCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </warrantCategory>
            <otherCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </otherCategory>
          </interestRtContracts>
          <otherContracts>
            <mon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <forwardCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </forwardCategory>
            <futureCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </futureCategory>
            <optionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </optionCategory>
            <swaptionCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swaptionCategory>
            <swapCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </swapCategory>
            <warrantCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </warrantCategory>
            <otherCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            </otherCategory>
          </otherContracts>
        </monthlyReturnCats>
        <othMon1 netRealizedGain="-2435064.27000000" netUnrealizedAppr="35068815.93000000"/>
        <othMon2 netRealizedGain="28641988.71000000" netUnrealizedAppr="85259246.04000000"/>
        <othMon3 netRealizedGain="25164215.89000000" netUnrealizedAppr="-48687562.67000000"/>
      </returnInfo>
      <mon1Flow redemption="17372601.80999999" reinvestment="0.00000000" sales="10304000.66000000"/>
      <mon2Flow redemption="15463222.77000000" reinvestment="0.00000000" sales="12891299.14000000"/>
      <mon3Flow redemption="16779007.88000000" reinvestment="0.23000000" sales="22929091.83000000"/>



    </fundInfo>
    <invstOrSecs>
      <invstOrSec>
        <name>Abivax SA</name>
        <lei>969500D8TMNB184OJU95</lei>
        <title>Abivax SA</title>
        <cusip>00370M103</cusip>
        <identifiers>
          <isin value="US00370M1036"/>
          <other otherDesc="Inhouse Asset ID" value="1305623"/>
        </identifiers>
        <balance>109022.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>13619028.24000000</valUSD>
        <pctVal>1.179905999697</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>FR</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Achieve Life Sciences, Inc.</name>
        <lei>549300V82ZKZDTAU0A46</lei>
        <title>Achieve Life Sciences, Inc.</title>
        <cusip>004468500</cusip>
        <identifiers>
          <isin value="US0044685008"/>
          <other otherDesc="Inhouse Asset ID" value="237754"/>
        </identifiers>
        <balance>1095791.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7034978.22000000</valUSD>
        <pctVal>0.609486437889</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="6359594.22000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Acumen Pharmaceuticals, Inc.</name>
        <lei>N/A</lei>
        <title>Acumen Pharmaceuticals, Inc.</title>
        <cusip>00509G209</cusip>
        <identifiers>
          <isin value="US00509G2093"/>
          <other otherDesc="Inhouse Asset ID" value="1152418"/>
        </identifiers>
        <balance>826400.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1776760.00000000</valUSD>
        <pctVal>0.153932405974</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Adicet Bio, Inc.</name>
        <lei>549300VRD2QO80WBOP18</lei>
        <title>Adicet Bio, Inc.</title>
        <cusip>007002207</cusip>
        <identifiers>
          <isin value="US0070022076"/>
          <other otherDesc="Inhouse Asset ID" value="821746"/>
        </identifiers>
        <balance>225186.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2051444.46000000</valUSD>
        <pctVal>0.177730127564</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Spyre Therapeutics, Inc.</name>
        <lei>52990017AIJPRH3HQH40</lei>
        <title>Spyre Therapeutics, Inc.</title>
        <cusip>00773J202</cusip>
        <identifiers>
          <isin value="US00773J2024"/>
          <other otherDesc="Inhouse Asset ID" value="630868"/>
        </identifiers>
        <balance>25009.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2459134.97000000</valUSD>
        <pctVal>0.213051038153</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Jade Biosciences, Inc.</name>
        <lei>N/A</lei>
        <title>Jade Biosciences, Inc.</title>
        <cusip>008064206</cusip>
        <identifiers>
          <isin value="US0080642061"/>
          <other otherDesc="Inhouse Asset ID" value="1467525"/>
        </identifiers>
        <balance>479949.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>9478992.75000000</valUSD>
        <pctVal>0.821227492866</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Alnylam Pharmaceuticals, Inc.</name>
        <lei>529900S3ZI14OWRJII50</lei>
        <title>Alnylam Pharmaceuticals, Inc.</title>
        <cusip>02043Q107</cusip>
        <identifiers>
          <isin value="US02043Q1076"/>
          <other otherDesc="Inhouse Asset ID" value="335788"/>
        </identifiers>
        <balance>51286.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>10540298.72000000</valUSD>
        <pctVal>0.913175410107</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Alto Neuroscience, Inc.</name>
        <lei>N/A</lei>
        <title>Alto Neuroscience, Inc.</title>
        <cusip>02157Q109</cusip>
        <identifiers>
          <isin value="US02157Q1094"/>
          <other otherDesc="Inhouse Asset ID" value="1324662"/>
        </identifiers>
        <balance>182834.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4949316.38000000</valUSD>
        <pctVal>0.428791833620</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Amgen, Inc.</name>
        <lei>62QBXGPJ34PQ72Z12S66</lei>
        <title>Amgen, Inc.</title>
        <cusip>031162100</cusip>
        <identifiers>
          <isin value="US0311621009"/>
          <other otherDesc="Inhouse Asset ID" value="17517"/>
        </identifiers>
        <balance>131554.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>50669338.64000000</valUSD>
        <pctVal>4.389818099241</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Amylyx Pharmaceuticals, Inc.</name>
        <lei>N/A</lei>
        <title>Amylyx Pharmaceuticals, Inc.</title>
        <cusip>03237H101</cusip>
        <identifiers>
          <isin value="US03237H1014"/>
          <other otherDesc="Inhouse Asset ID" value="1183738"/>
        </identifiers>
        <balance>752824.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>15289855.44000000</valUSD>
        <pctVal>1.324660750403</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Arcutis Biotherapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Arcutis Biotherapeutics, Inc.</title>
        <cusip>03969K108</cusip>
        <identifiers>
          <isin value="US03969K1088"/>
          <other otherDesc="Inhouse Asset ID" value="1041134"/>
        </identifiers>
        <balance>505651.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>13581785.86000000</valUSD>
        <pctVal>1.176679447344</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Argenx SE</name>
        <lei>7245009C5FZE6G9ODQ71</lei>
        <title>Argenx SE</title>
        <cusip>04016X101</cusip>
        <identifiers>
          <isin value="US04016X1019"/>
          <other otherDesc="Inhouse Asset ID" value="666159"/>
        </identifiers>
        <balance>48962.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>41804734.84000000</valUSD>
        <pctVal>3.621819162441</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>NL</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Artiva Biotherapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Artiva Biotherapeutics, Inc.</title>
        <cusip>04317A107</cusip>
        <identifiers>
          <isin value="US04317A1079"/>
          <other otherDesc="Inhouse Asset ID" value="1374583"/>
        </identifiers>
        <balance>542371.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5477947.10000000</valUSD>
        <pctVal>0.474590590122</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1544290.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Assembly Biosciences, Inc.</name>
        <lei>5299007Y1X8RBDFT8C40</lei>
        <title>Assembly Biosciences, Inc.</title>
        <cusip>045396207</cusip>
        <identifiers>
          <isin value="US0453962070"/>
          <other otherDesc="Inhouse Asset ID" value="599501"/>
        </identifiers>
        <balance>40982.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1029058.02000000</valUSD>
        <pctVal>0.089154065212</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="657882.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Aura Biosciences, Inc.</name>
        <lei>N/A</lei>
        <title>Aura Biosciences, Inc.</title>
        <cusip>05153U107</cusip>
        <identifiers>
          <isin value="US05153U1079"/>
          <other otherDesc="Inhouse Asset ID" value="1183184"/>
        </identifiers>
        <balance>765617.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5366975.17000000</valUSD>
        <pctVal>0.464976361875</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="171745.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Avalo Therapeutics, Inc.</name>
        <lei>549300GPK6FPJ3X8SZ39</lei>
        <title>Avalo Therapeutics, Inc.</title>
        <cusip>05338F306</cusip>
        <identifiers>
          <isin value="US05338F3064"/>
          <other otherDesc="Inhouse Asset ID" value="633990"/>
        </identifiers>
        <balance>147877.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2698755.25000000</valUSD>
        <pctVal>0.233810919184</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Avalyn Pharma, Inc.</name>
        <lei>N/A</lei>
        <title>Avalyn Pharma, Inc.</title>
        <cusip>05348Y105</cusip>
        <identifiers>
          <isin value="US05348Y1055"/>
          <other otherDesc="Inhouse Asset ID" value="1611340"/>
        </identifiers>
        <balance>120364.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3465279.56000000</valUSD>
        <pctVal>0.300219962204</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="3290697.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Bicara Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Bicara Therapeutics, Inc.</title>
        <cusip>055477103</cusip>
        <identifiers>
          <isin value="US0554771032"/>
          <other otherDesc="Inhouse Asset ID" value="1392673"/>
        </identifiers>
        <balance>474899.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>12869762.90000000</valUSD>
        <pctVal>1.114992214774</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BeOne Medicines Ltd.</name>
        <lei>549300JFUK6FRD5MH739</lei>
        <title>BeOne Medicines Ltd.</title>
        <cusip>07725L102</cusip>
        <identifiers>
          <isin value="US07725L1026"/>
          <other otherDesc="Inhouse Asset ID" value="654465"/>
        </identifiers>
        <balance>33421.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>10561370.21000000</valUSD>
        <pctVal>0.915000971890</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CH</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Benitec Biopharma, Inc.</name>
        <lei>N/A</lei>
        <title>Benitec Biopharma, Inc.</title>
        <cusip>08205P209</cusip>
        <identifiers>
          <isin value="US08205P2092"/>
          <other otherDesc="Inhouse Asset ID" value="1204961"/>
        </identifiers>
        <balance>995152.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>11653229.92000000</valUSD>
        <pctVal>1.009595960604</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BioNTech SE</name>
        <lei>894500UZJ5LG1F8J1U58</lei>
        <title>BioNTech SE</title>
        <cusip>09075V102</cusip>
        <identifiers>
          <isin value="US09075V1026"/>
          <other otherDesc="Inhouse Asset ID" value="1046248"/>
        </identifiers>
        <balance>73400.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>6648572.00000000</valUSD>
        <pctVal>0.576009525347</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>DE</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>BioAge Labs, Inc.</name>
        <lei>529900NG0C40250Z7875</lei>
        <title>BioAge Labs, Inc.</title>
        <cusip>09077V100</cusip>
        <identifiers>
          <isin value="US09077V1008"/>
          <other otherDesc="Inhouse Asset ID" value="1397817"/>
        </identifiers>
        <balance>135049.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1220842.96000000</valUSD>
        <pctVal>0.105769656087</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Sanofi SA</name>
        <lei>N/A</lei>
        <title>Sanofi SA, Escrow Account</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Inhouse Asset ID" value="1187453"/>
        </identifiers>
        <balance>2333755.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2.33000000</valUSD>
        <pctVal>0.000000201863</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CO</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>3</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Bridgebio Pharma, Inc.</name>
        <lei>54930028YG89VTY2J114</lei>
        <title>Bridgebio Pharma, Inc.</title>
        <cusip>10806X102</cusip>
        <identifiers>
          <isin value="US10806X1028"/>
          <other otherDesc="Inhouse Asset ID" value="992939"/>
        </identifiers>
        <balance>241119.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>19311220.71000000</valUSD>
        <pctVal>1.673058075486</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Cabaletta Bio, Inc.</name>
        <lei>N/A</lei>
        <title>Cabaletta Bio, Inc.</title>
        <cusip>12674W109</cusip>
        <identifiers>
          <isin value="US12674W1099"/>
          <other otherDesc="Inhouse Asset ID" value="1018189"/>
        </identifiers>
        <balance>876846.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2349947.28000000</valUSD>
        <pctVal>0.203591390353</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1024028.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Cardiff Oncology, Inc.</name>
        <lei>549300AHOLZBHHYFWP04</lei>
        <title>Cardiff Oncology, Inc.</title>
        <cusip>14147L108</cusip>
        <identifiers>
          <isin value="US14147L1089"/>
          <other otherDesc="Inhouse Asset ID" value="562112"/>
        </identifiers>
        <balance>438961.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>375487.24000000</valUSD>
        <pctVal>0.032530929481</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="356701.80000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Celcuity, Inc.</name>
        <lei>25490070W7UU7W2SEY87</lei>
        <title>Celcuity, Inc.</title>
        <cusip>15102K100</cusip>
        <identifiers>
          <isin value="US15102K1007"/>
          <other otherDesc="Inhouse Asset ID" value="814746"/>
        </identifiers>
        <balance>46107.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3982722.66000000</valUSD>
        <pctVal>0.345049461595</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>CG oncology, Inc.</name>
        <lei>N/A</lei>
        <title>CG oncology, Inc.</title>
        <cusip>156944100</cusip>
        <identifiers>
          <isin value="US1569441009"/>
          <other otherDesc="Inhouse Asset ID" value="1323393"/>
        </identifiers>
        <balance>174532.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>12424933.08000000</valUSD>
        <pctVal>1.076453681465</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Cogent Biosciences, Inc.</name>
        <lei>N/A</lei>
        <title>Cogent Biosciences, Inc.</title>
        <cusip>19240Q201</cusip>
        <identifiers>
          <isin value="US19240Q2012"/>
          <other otherDesc="Inhouse Asset ID" value="825365"/>
        </identifiers>
        <balance>75829.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2952022.97000000</valUSD>
        <pctVal>0.255753167712</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Context Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Context Therapeutics, Inc.</title>
        <cusip>21077P108</cusip>
        <identifiers>
          <isin value="US21077P1084"/>
          <other otherDesc="Inhouse Asset ID" value="1157131"/>
        </identifiers>
        <balance>1398833.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>838460.50000000</valUSD>
        <pctVal>0.072641348341</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Contineum Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Contineum Therapeutics, Inc., Class A</title>
        <cusip>21217B100</cusip>
        <identifiers>
          <isin value="US21217B1008"/>
          <other otherDesc="Inhouse Asset ID" value="1343814"/>
        </identifiers>
        <balance>330090.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5113094.10000000</valUSD>
        <pctVal>0.442980974801</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Cytokinetics, Inc.</name>
        <lei>549300BE5DY1HW7IHA64</lei>
        <title>Cytokinetics, Inc.</title>
        <cusip>23282W605</cusip>
        <identifiers>
          <isin value="US23282W6057"/>
          <other otherDesc="Inhouse Asset ID" value="303973"/>
        </identifiers>
        <balance>186018.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>14347568.34000000</valUSD>
        <pctVal>1.243024220752</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Definium Therapeutics, Inc.</name>
        <lei>549300QY8KN1O6RPFJ13</lei>
        <title>Definium Therapeutics, Inc.</title>
        <cusip>24477V105</cusip>
        <identifiers>
          <isin value="CA24477V1058"/>
          <other otherDesc="Inhouse Asset ID" value="1131023"/>
        </identifiers>
        <balance>86980.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3785369.60000000</valUSD>
        <pctVal>0.327951467858</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CA</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Dianthus Therapeutics, Inc.</name>
        <lei>549300Z3N6ODPCOFC890</lei>
        <title>Dianthus Therapeutics, Inc.</title>
        <cusip>252828108</cusip>
        <identifiers>
          <isin value="US2528281080"/>
          <other otherDesc="Inhouse Asset ID" value="878152"/>
        </identifiers>
        <balance>250308.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>26762931.36000000</valUSD>
        <pctVal>2.318648784970</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Dyne Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Dyne Therapeutics, Inc.</title>
        <cusip>26818M108</cusip>
        <identifiers>
          <isin value="US26818M1080"/>
          <other otherDesc="Inhouse Asset ID" value="1108547"/>
        </identifiers>
        <balance>519232.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>13074261.76000000</valUSD>
        <pctVal>1.132709296168</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Eikon Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Eikon Therapeutics, Inc.</title>
        <cusip>282564103</cusip>
        <identifiers>
          <isin value="US2825641036"/>
          <other otherDesc="Inhouse Asset ID" value="1571756"/>
        </identifiers>
        <balance>127376.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1173132.96000000</valUSD>
        <pctVal>0.101636224960</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="170385.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>EyePoint, Inc.</name>
        <lei>549300QE1RU34T50MR69</lei>
        <title>EyePoint, Inc.</title>
        <cusip>30233G209</cusip>
        <identifiers>
          <isin value="US30233G2093"/>
          <other otherDesc="Inhouse Asset ID" value="590064"/>
        </identifiers>
        <balance>1123495.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>13762813.75000000</valUSD>
        <pctVal>1.192363084221</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Gilead Sciences, Inc.</name>
        <lei>549300WTZWR07K8MNV44</lei>
        <title>Gilead Sciences, Inc.</title>
        <cusip>375558103</cusip>
        <identifiers>
          <isin value="US3755581036"/>
          <other otherDesc="Inhouse Asset ID" value="29819"/>
        </identifiers>
        <balance>341817.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>44507991.57000000</valUSD>
        <pctVal>3.856020074448</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>GRAIL, Inc.</name>
        <lei>2549009XSNESW3VE8024</lei>
        <title>GRAIL, Inc.</title>
        <cusip>384747101</cusip>
        <identifiers>
          <isin value="US3847471014"/>
          <other otherDesc="Inhouse Asset ID" value="1364116"/>
        </identifiers>
        <balance>46433.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3183446.48000000</valUSD>
        <pctVal>0.275802908641</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Guardant Health, Inc.</name>
        <lei>254900M8C3E5VC8BR186</lei>
        <title>Guardant Health, Inc.</title>
        <cusip>40131M109</cusip>
        <identifiers>
          <isin value="US40131M1099"/>
          <other otherDesc="Inhouse Asset ID" value="934353"/>
        </identifiers>
        <balance>196520.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>31834274.80000000</valUSD>
        <pctVal>2.758012625468</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Ideaya Biosciences, Inc.</name>
        <lei>549300ULW08F62IJML11</lei>
        <title>Ideaya Biosciences, Inc.</title>
        <cusip>45166A102</cusip>
        <identifiers>
          <isin value="US45166A1025"/>
          <other otherDesc="Inhouse Asset ID" value="985436"/>
        </identifiers>
        <balance>81852.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2905746.00000000</valUSD>
        <pctVal>0.251743889400</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Immix Biopharma, Inc.</name>
        <lei>N/A</lei>
        <title>Immix Biopharma, Inc.</title>
        <cusip>45258H106</cusip>
        <identifiers>
          <isin value="US45258H1068"/>
          <other otherDesc="Inhouse Asset ID" value="1181559"/>
        </identifiers>
        <balance>357034.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2970522.88000000</valUSD>
        <pctVal>0.257355936604</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="108825.60000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Indivior Pharmaceuticals, Inc.</name>
        <lei>254900MKFFZZSS7N1I14</lei>
        <title>Indivior Pharmaceuticals, Inc.</title>
        <cusip>45579U109</cusip>
        <identifiers>
          <isin value="US45579U1097"/>
          <other otherDesc="Inhouse Asset ID" value="1566912"/>
        </identifiers>
        <balance>332496.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>13303164.96000000</valUSD>
        <pctVal>1.152540686064</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>IN8bio, Inc.</name>
        <lei>549300H68IVCRKSGSL94</lei>
        <title>IN8bio, Inc.</title>
        <cusip>45674E208</cusip>
        <identifiers>
          <isin value="US45674E2081"/>
          <other otherDesc="Inhouse Asset ID" value="1121784"/>
        </identifiers>
        <balance>332083.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>345366.32000000</valUSD>
        <pctVal>0.029921356052</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Insmed, Inc.</name>
        <lei>529900Q55QAG41CCAC11</lei>
        <title>Insmed, Inc.</title>
        <cusip>457669307</cusip>
        <identifiers>
          <isin value="US4576693075"/>
          <other otherDesc="Inhouse Asset ID" value="236275"/>
        </identifiers>
        <balance>233052.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>22978927.20000000</valUSD>
        <pctVal>1.990815614160</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Franklin Institutional U.S. Government Money Market Fund</name>
        <lei>549300M4TP89K77LG374</lei>
        <title>Franklin Institutional U.S. Government Money Market Fund</title>
        <cusip>457756500</cusip>
        <identifiers>
          <isin value="US4577565009"/>
          <other otherDesc="Inhouse Asset ID" value="170875"/>
        </identifiers>
        <balance>16697192.88000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>16697192.88000000</valUSD>
        <pctVal>1.446587650016</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>STIV</assetCat>
        <issuerCat>RF</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Inventiva SACA</name>
        <lei>969500I9Y690B3FZW590</lei>
        <title>Inventiva SACA</title>
        <cusip>46124U107</cusip>
        <identifiers>
          <isin value="US46124U1079"/>
          <other otherDesc="Inhouse Asset ID" value="1543438"/>
        </identifiers>
        <balance>1014919.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4546837.12000000</valUSD>
        <pctVal>0.393922407898</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>FR</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="738752.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Ionis Pharmaceuticals, Inc.</name>
        <lei>549300SI4ZGLG0BLUZ92</lei>
        <title>Ionis Pharmaceuticals, Inc.</title>
        <cusip>462222100</cusip>
        <identifiers>
          <isin value="US4622221004"/>
          <other otherDesc="Inhouse Asset ID" value="39884"/>
        </identifiers>
        <balance>209423.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>10841828.71000000</valUSD>
        <pctVal>0.939298936545</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Kailera Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Kailera Therapeutics, Inc.</title>
        <cusip>482931102</cusip>
        <identifiers>
          <isin value="US4829311020"/>
          <other otherDesc="Inhouse Asset ID" value="1607992"/>
        </identifiers>
        <balance>146385.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2479761.90000000</valUSD>
        <pctVal>0.214838084778</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1875258.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Kardigan, Inc.</name>
        <lei>N/A</lei>
        <title>Kardigan, Inc.</title>
        <cusip>485925101</cusip>
        <identifiers>
          <isin value="US4859251013"/>
          <other otherDesc="Inhouse Asset ID" value="1626677"/>
        </identifiers>
        <balance>144820.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3015152.40000000</valUSD>
        <pctVal>0.261222485486</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1569828.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Krystal Biotech, Inc.</name>
        <lei>549300YONUY68210OE41</lei>
        <title>Krystal Biotech, Inc.</title>
        <cusip>501147102</cusip>
        <identifiers>
          <isin value="US5011471027"/>
          <other otherDesc="Inhouse Asset ID" value="814747"/>
        </identifiers>
        <balance>14607.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4982739.84000000</valUSD>
        <pctVal>0.431687527813</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Eli Lilly &amp; Co.</name>
        <lei>FRDRIPF3EKNDJ2CQJL29</lei>
        <title>Eli Lilly &amp; Co.</title>
        <cusip>532457108</cusip>
        <identifiers>
          <isin value="US5324571083"/>
          <other otherDesc="Inhouse Asset ID" value="16427"/>
        </identifiers>
        <balance>13131.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>15085418.04000000</valUSD>
        <pctVal>1.306948993692</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>MBX Biosciences, Inc.</name>
        <lei>N/A</lei>
        <title>MBX Biosciences, Inc.</title>
        <cusip>55287L101</cusip>
        <identifiers>
          <isin value="US55287L1017"/>
          <other otherDesc="Inhouse Asset ID" value="1392671"/>
        </identifiers>
        <balance>85528.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5638861.04000000</valUSD>
        <pctVal>0.488531623204</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Sartorius AG</name>
        <lei>529900EQV2DY4FOAMU38</lei>
        <title>Sartorius AG</title>
        <cusip>N/A</cusip>
        <identifiers>
          <isin value="DE0007165631"/>
          <other otherDesc="Inhouse Asset ID" value="313274"/>
        </identifiers>
        <balance>9200.00000000</balance>
        <units>NS</units>
        <currencyConditional curCd="EUR" exchangeRt="0.86718987"/>
        <valUSD>2318711.84000000</valUSD>
        <pctVal>0.200885258725</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EP</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>DE</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Mineralys Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Mineralys Therapeutics, Inc.</title>
        <cusip>603170101</cusip>
        <identifiers>
          <isin value="US6031701013"/>
          <other otherDesc="Inhouse Asset ID" value="1237277"/>
        </identifiers>
        <balance>533511.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>13615200.72000000</valUSD>
        <pctVal>1.179574396462</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Mirum Pharmaceuticals, Inc.</name>
        <lei>254900YZKR40F7F27K81</lei>
        <title>Mirum Pharmaceuticals, Inc.</title>
        <cusip>604749101</cusip>
        <identifiers>
          <isin value="US6047491013"/>
          <other otherDesc="Inhouse Asset ID" value="998028"/>
        </identifiers>
        <balance>215190.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>22799380.50000000</valUSD>
        <pctVal>1.975260302517</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Neurocrine Biosciences, Inc.</name>
        <lei>549300FECER0XBN49756</lei>
        <title>Neurocrine Biosciences, Inc.</title>
        <cusip>64125C109</cusip>
        <identifiers>
          <isin value="US64125C1099"/>
          <other otherDesc="Inhouse Asset ID" value="190162"/>
        </identifiers>
        <balance>125643.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>20957252.40000000</valUSD>
        <pctVal>1.815664628060</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Neurogene, Inc.</name>
        <lei>529900A7VIY892SZVW73</lei>
        <title>Neurogene, Inc.</title>
        <cusip>64135M105</cusip>
        <identifiers>
          <isin value="US64135M1053"/>
          <other otherDesc="Inhouse Asset ID" value="572130"/>
        </identifiers>
        <balance>218783.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7195772.87000000</valUSD>
        <pctVal>0.623417136094</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Odyssey Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Odyssey Therapeutics, Inc.</title>
        <cusip>67613T104</cusip>
        <identifiers>
          <isin value="US67613T1043"/>
          <other otherDesc="Inhouse Asset ID" value="1614560"/>
        </identifiers>
        <balance>99826.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1889706.18000000</valUSD>
        <pctVal>0.163717676485</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1794564.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Olema Pharmaceuticals, Inc.</name>
        <lei>N/A</lei>
        <title>Olema Pharmaceuticals, Inc.</title>
        <cusip>68062P106</cusip>
        <identifiers>
          <isin value="US68062P1066"/>
          <other otherDesc="Inhouse Asset ID" value="1122527"/>
        </identifiers>
        <balance>568915.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>6514076.75000000</valUSD>
        <pctVal>0.564357317157</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>ORIC Pharmaceuticals, Inc.</name>
        <lei>54930033FJRNEYBW0L25</lei>
        <title>ORIC Pharmaceuticals, Inc.</title>
        <cusip>68622P109</cusip>
        <identifiers>
          <isin value="US68622P1093"/>
          <other otherDesc="Inhouse Asset ID" value="1065258"/>
        </identifiers>
        <balance>659005.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7295185.35000000</valUSD>
        <pctVal>0.632029893152</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Oruka Therapeutics, Inc.</name>
        <lei>529900TG7O4ESUDMGI54</lei>
        <title>Oruka Therapeutics, Inc.</title>
        <cusip>687604108</cusip>
        <identifiers>
          <isin value="US6876041087"/>
          <other otherDesc="Inhouse Asset ID" value="48080"/>
        </identifiers>
        <balance>73869.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7129097.19000000</valUSD>
        <pctVal>0.617640583356</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>PTC Therapeutics, Inc.</name>
        <lei>549300UJLWOIWFDGB318</lei>
        <title>PTC Therapeutics, Inc.</title>
        <cusip>69366J200</cusip>
        <identifiers>
          <isin value="US69366J2006"/>
          <other otherDesc="Inhouse Asset ID" value="552507"/>
        </identifiers>
        <balance>279737.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>19024913.37000000</valUSD>
        <pctVal>1.648253387349</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Palisade Bio, Inc.</name>
        <lei>549300W6LIDX3I5XXT34</lei>
        <title>Palisade Bio, Inc.</title>
        <cusip>696389154</cusip>
        <identifiers>
          <isin value="US6963891543"/>
          <other otherDesc="Inhouse Asset ID" value="1527672"/>
        </identifiers>
        <balance>1447549.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2742960.60000000</valUSD>
        <pctVal>0.237640719428</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetConditional assetCat="OTHER" desc="Warrant"/>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>3</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Palisade Bio, Inc.</name>
        <lei>549300W6LIDX3I5XXT34</lei>
        <title>Palisade Bio, Inc.</title>
        <cusip>696389402</cusip>
        <identifiers>
          <isin value="US6963894026"/>
          <other otherDesc="Inhouse Asset ID" value="474869"/>
        </identifiers>
        <balance>2119910.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4017229.45000000</valUSD>
        <pctVal>0.348039011791</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Parabilis Medicines, Inc.</name>
        <lei>N/A</lei>
        <title>Parabilis Medicines, Inc.</title>
        <cusip>698955101</cusip>
        <identifiers>
          <isin value="US6989551014"/>
          <other otherDesc="Inhouse Asset ID" value="1624744"/>
        </identifiers>
        <balance>93010.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3160479.80000000</valUSD>
        <pctVal>0.273813154083</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="3000434.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Phathom Pharmaceuticals, Inc.</name>
        <lei>N/A</lei>
        <title>Phathom Pharmaceuticals, Inc.</title>
        <cusip>71722W107</cusip>
        <identifiers>
          <isin value="US71722W1071"/>
          <other otherDesc="Inhouse Asset ID" value="1018190"/>
        </identifiers>
        <balance>507425.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4439968.75000000</valUSD>
        <pctVal>0.384663698046</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Praxis Precision Medicines, Inc.</name>
        <lei>N/A</lei>
        <title>Praxis Precision Medicines, Inc.</title>
        <cusip>74006W207</cusip>
        <identifiers>
          <isin value="US74006W2070"/>
          <other otherDesc="Inhouse Asset ID" value="1114967"/>
        </identifiers>
        <balance>71799.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>22101886.17000000</valUSD>
        <pctVal>1.914831780729</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Regeneron Pharmaceuticals, Inc.</name>
        <lei>549300RCBFWIRX3HYQ56</lei>
        <title>Regeneron Pharmaceuticals, Inc.</title>
        <cusip>75886F107</cusip>
        <identifiers>
          <isin value="US75886F1075"/>
          <other otherDesc="Inhouse Asset ID" value="203818"/>
        </identifiers>
        <balance>57013.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>43479824.19000000</valUSD>
        <pctVal>3.766943171237</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Relay Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Relay Therapeutics, Inc.</title>
        <cusip>75943R102</cusip>
        <identifiers>
          <isin value="US75943R1023"/>
          <other otherDesc="Inhouse Asset ID" value="1092401"/>
        </identifiers>
        <balance>404940.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7625020.20000000</valUSD>
        <pctVal>0.660605655796</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Relmada Therapeutics, Inc.</name>
        <lei>549300217EASRZ9JSF81</lei>
        <title>Relmada Therapeutics, Inc.</title>
        <cusip>75955J402</cusip>
        <identifiers>
          <isin value="US75955J4022"/>
          <other otherDesc="Inhouse Asset ID" value="1026454"/>
        </identifiers>
        <balance>788718.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4188092.58000000</valUSD>
        <pctVal>0.362842008647</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Revolution Medicines, Inc.</name>
        <lei>549300JU3X0LBCQ65892</lei>
        <title>Revolution Medicines, Inc.</title>
        <cusip>76155X100</cusip>
        <identifiers>
          <isin value="US76155X1000"/>
          <other otherDesc="Inhouse Asset ID" value="1042215"/>
        </identifiers>
        <balance>185428.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>34773312.84000000</valUSD>
        <pctVal>3.012640823282</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Benitec Biopharma, Inc.</name>
        <lei>N/A</lei>
        <title>Benitec Biopharma, Inc.</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Inhouse Asset ID" value="1286257"/>
        </identifiers>
        <balance>310881.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3640385.42000000</valUSD>
        <pctVal>0.315390534667</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>3</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Satellos Bioscience, Inc.</name>
        <lei>529900EN243BZ5QC9N39</lei>
        <title>Satellos Bioscience, Inc.</title>
        <cusip>80401L803</cusip>
        <identifiers>
          <isin value="CA80401L8033"/>
          <other otherDesc="Inhouse Asset ID" value="1574633"/>
        </identifiers>
        <balance>246407.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2461605.93000000</valUSD>
        <pctVal>0.213265113671</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CA</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Scribe Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Scribe Therapeutics, Inc.</title>
        <cusip>811033109</cusip>
        <identifiers>
          <isin value="US8110331092"/>
          <other otherDesc="Inhouse Asset ID" value="1637150"/>
        </identifiers>
        <balance>135567.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2640845.16000000</valUSD>
        <pctVal>0.228793787166</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="2260517.64000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Faeth Therapeutics, Inc.</name>
        <lei>8945002MP2CXKAENWU30</lei>
        <title>Faeth Therapeutics, Inc.</title>
        <cusip>81728A207</cusip>
        <identifiers>
          <isin value="US81728A2078"/>
          <other otherDesc="Inhouse Asset ID" value="1132696"/>
        </identifiers>
        <balance>180711.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4922567.64000000</valUSD>
        <pctVal>0.426474414326</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="3326004.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Sionna Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Sionna Therapeutics, Inc.</title>
        <cusip>829401108</cusip>
        <identifiers>
          <isin value="US8294011080"/>
          <other otherDesc="Inhouse Asset ID" value="1442298"/>
        </identifiers>
        <balance>107956.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5087966.28000000</valUSD>
        <pctVal>0.440803986469</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="150816.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Solid Biosciences, Inc.</name>
        <lei>N/A</lei>
        <title>Solid Biosciences, Inc.</title>
        <cusip>83422E204</cusip>
        <identifiers>
          <isin value="US83422E2046"/>
          <other otherDesc="Inhouse Asset ID" value="821672"/>
        </identifiers>
        <balance>1409093.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>11357289.58000000</valUSD>
        <pctVal>0.983956702313</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>SpyGlass Pharma, Inc.</name>
        <lei>N/A</lei>
        <title>SpyGlass Pharma, Inc.</title>
        <cusip>85220G109</cusip>
        <identifiers>
          <isin value="US85220G1094"/>
          <other otherDesc="Inhouse Asset ID" value="1574211"/>
        </identifiers>
        <balance>84708.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1908471.24000000</valUSD>
        <pctVal>0.165343417066</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1741569.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Structure Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Structure Therapeutics, Inc.</title>
        <cusip>86366E106</cusip>
        <identifiers>
          <isin value="US86366E1064"/>
          <other otherDesc="Inhouse Asset ID" value="1236609"/>
        </identifiers>
        <balance>101791.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4890039.64000000</valUSD>
        <pctVal>0.423656299723</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Syndax Pharmaceuticals, Inc.</name>
        <lei>529900OF94TRHKZVBS87</lei>
        <title>Syndax Pharmaceuticals, Inc.</title>
        <cusip>87164F105</cusip>
        <identifiers>
          <isin value="US87164F1057"/>
          <other otherDesc="Inhouse Asset ID" value="578995"/>
        </identifiers>
        <balance>582815.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>11102625.75000000</valUSD>
        <pctVal>0.961893499592</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Tango Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Tango Therapeutics, Inc.</title>
        <cusip>87583X109</cusip>
        <identifiers>
          <isin value="US87583X1090"/>
          <other otherDesc="Inhouse Asset ID" value="1204013"/>
        </identifiers>
        <balance>521761.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>14181463.98000000</valUSD>
        <pctVal>1.228633507444</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Thermo Fisher Scientific, Inc.</name>
        <lei>HCHV7422L5HDJZCRFL38</lei>
        <title>Thermo Fisher Scientific, Inc.</title>
        <cusip>883556102</cusip>
        <identifiers>
          <isin value="US8835561023"/>
          <other otherDesc="Inhouse Asset ID" value="30383"/>
        </identifiers>
        <balance>22999.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>13208325.70000000</valUSD>
        <pctVal>1.144324137137</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Tyra Biosciences, Inc.</name>
        <lei>N/A</lei>
        <title>Tyra Biosciences, Inc.</title>
        <cusip>90240B106</cusip>
        <identifiers>
          <isin value="US90240B1061"/>
          <other otherDesc="Inhouse Asset ID" value="1165403"/>
        </identifiers>
        <balance>62752.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2000533.76000000</valUSD>
        <pctVal>0.173319398743</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Ultragenyx Pharmaceutical, Inc.</name>
        <lei>529900EV44GVDN1DCX77</lei>
        <title>Ultragenyx Pharmaceutical, Inc.</title>
        <cusip>90400D108</cusip>
        <identifiers>
          <isin value="US90400D1081"/>
          <other otherDesc="Inhouse Asset ID" value="569323"/>
        </identifiers>
        <balance>108067.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2691948.97000000</valUSD>
        <pctVal>0.233221246377</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Vaxcyte, Inc.</name>
        <lei>254900M7NMHTGASX8D95</lei>
        <title>Vaxcyte, Inc.</title>
        <cusip>92243G108</cusip>
        <identifiers>
          <isin value="US92243G1085"/>
          <other otherDesc="Inhouse Asset ID" value="1080340"/>
        </identifiers>
        <balance>145674.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7878049.92000000</valUSD>
        <pctVal>0.682527284819</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>VeraDermics, Inc.</name>
        <lei>N/A</lei>
        <title>VeraDermics, Inc.</title>
        <cusip>922967104</cusip>
        <identifiers>
          <isin value="US9229671048"/>
          <other otherDesc="Inhouse Asset ID" value="1569408"/>
        </identifiers>
        <balance>31081.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3263505.00000000</valUSD>
        <pctVal>0.282738904838</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="2394000.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Verastem, Inc.</name>
        <lei>549300IY0EFBIU8NQC81</lei>
        <title>Verastem, Inc.</title>
        <cusip>92337C203</cusip>
        <identifiers>
          <isin value="US92337C2035"/>
          <other otherDesc="Inhouse Asset ID" value="513295"/>
        </identifiers>
        <balance>401744.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2330115.20000000</valUSD>
        <pctVal>0.201873206811</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Vertex Pharmaceuticals, Inc.</name>
        <lei>54930015RAQRRZ5ZGJ91</lei>
        <title>Vertex Pharmaceuticals, Inc.</title>
        <cusip>92532F100</cusip>
        <identifiers>
          <isin value="US92532F1003"/>
          <other otherDesc="Inhouse Asset ID" value="43691"/>
        </identifiers>
        <balance>85620.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>40849302.00000000</valUSD>
        <pctVal>3.539043730864</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Vor BioPharma, Inc.</name>
        <lei>N/A</lei>
        <title>Vor BioPharma, Inc.</title>
        <cusip>929033207</cusip>
        <identifiers>
          <isin value="US9290332074"/>
          <other otherDesc="Inhouse Asset ID" value="1132674"/>
        </identifiers>
        <balance>148745.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3145956.75000000</valUSD>
        <pctVal>0.272554926731</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Xenon Pharmaceuticals, Inc.</name>
        <lei>549300XV44Q9Z1MIPQ03</lei>
        <title>Xenon Pharmaceuticals, Inc.</title>
        <cusip>98420N105</cusip>
        <identifiers>
          <isin value="CA98420N1050"/>
          <other otherDesc="Inhouse Asset ID" value="615210"/>
        </identifiers>
        <balance>123767.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7756477.89000000</valUSD>
        <pctVal>0.671994700183</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CA</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>IN8bio, Inc.</name>
        <lei>549300H68IVCRKSGSL94</lei>
        <title>IN8bio, Inc., Series C</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Inhouse Asset ID" value="1400352"/>
        </identifiers>
        <balance>69673.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4.46000000</valUSD>
        <pctVal>0.000000386399</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetConditional assetCat="OTHER" desc="Warrant"/>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>Y</isRestrictedSec>

        <fairValLevel>3</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Achieve Life Sciences, Inc.</name>
        <lei>549300V82ZKZDTAU0A46</lei>
        <title>Achieve Life Sciences, Inc.</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Inhouse Asset ID" value="1490944"/>
        </identifiers>
        <balance>698900.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2390238.00000000</valUSD>
        <pctVal>0.207082040451</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetConditional assetCat="OTHER" desc="Warrant"/>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>3</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Assembly Biosciences, Inc.</name>
        <lei>5299007Y1X8RBDFT8C40</lei>
        <title>Assembly Biosciences, Inc., Series A</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Inhouse Asset ID" value="1505400"/>
        </identifiers>
        <balance>44450.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>445381.53000000</valUSD>
        <pctVal>0.038586331575</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>3</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Assembly Biosciences, Inc.</name>
        <lei>5299007Y1X8RBDFT8C40</lei>
        <title>Assembly Biosciences, Inc., Series B</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Inhouse Asset ID" value="1505410"/>
        </identifiers>
        <balance>44450.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>22556.37000000</valUSD>
        <pctVal>0.001954206704</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>3</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Acumen Pharmaceuticals, Inc.</name>
        <lei>N/A</lei>
        <title>Acumen Pharmaceuticals, Inc.</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Inhouse Asset ID" value="1588245"/>
        </identifiers>
        <balance>223305.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>480105.75000000</valUSD>
        <pctVal>0.041594719162</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>Y</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Obsidian Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Obsidian Therapeutics, Inc., Series C</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Inhouse Asset ID" value="1605076"/>
        </identifiers>
        <balance>4354.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>6385654.25000000</valUSD>
        <pctVal>0.553231231244</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>3</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Ray Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Ray Therapeutics, Inc., Series B</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Inhouse Asset ID" value="1608393"/>
        </identifiers>
        <balance>1389029.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3784235.88000000</valUSD>
        <pctVal>0.327853246237</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>Y</isRestrictedSec>

        <fairValLevel>3</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Achieve Life Sciences, Inc.</name>
        <lei>549300V82ZKZDTAU0A46</lei>
        <title>Achieve Life Sciences, Inc.</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Inhouse Asset ID" value="1607185"/>
        </identifiers>
        <balance>706649.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4536686.58000000</valUSD>
        <pctVal>0.393042999849</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>Y</isRestrictedSec>

        <fairValLevel>3</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Achieve Life Sciences, Inc.</name>
        <lei>549300V82ZKZDTAU0A46</lei>
        <title>Achieve Life Sciences, Inc.</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Inhouse Asset ID" value="1607189"/>
        </identifiers>
        <balance>706649.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2056348.59000000</valUSD>
        <pctVal>0.178155004604</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetConditional assetCat="OTHER" desc="Warrant"/>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>Y</isRestrictedSec>

        <fairValLevel>3</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Lycia Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Lycia Therapeutics, Inc., Series D</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Inhouse Asset ID" value="1624732"/>
        </identifiers>
        <balance>177052.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>426799.25000000</valUSD>
        <pctVal>0.036976426428</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EP</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>Y</isRestrictedSec>

        <fairValLevel>3</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Baylor College of Medicine</name>
        <lei>5493006UKJHZXSM3H989</lei>
        <title>Baylor Genetics Holdings, Inc., Series B</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Inhouse Asset ID" value="1627549"/>
        </identifiers>
        <balance>188069.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3433011.71000000</valUSD>
        <pctVal>0.297424386107</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EP</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>3</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Processa Pharmaceuticals, Inc.</name>
        <lei>529900A51HZIE4XJB960</lei>
        <title>Processa Pharmaceuticals, Inc., Series A</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Inhouse Asset ID" value="1639487"/>
        </identifiers>
        <balance>2862.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5513145.75000000</valUSD>
        <pctVal>0.477640080701</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EP</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>Y</isRestrictedSec>

        <fairValLevel>3</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Oruka Therapeutics, Inc.</name>
        <lei>529900TG7O4ESUDMGI54</lei>
        <title>Oruka Therapeutics, Inc.</title>
        <cusip>687604108</cusip>
        <identifiers>
          <isin value="US6876041087"/>
          <other otherDesc="Inhouse Asset ID" value="48080"/>
        </identifiers>
        <balance>222393.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>21463148.43000000</valUSD>
        <pctVal>1.859493728823</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Contineum Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Contineum Therapeutics, Inc., Class A</title>
        <cusip>21217B100</cusip>
        <identifiers>
          <isin value="US21217B1008"/>
          <other otherDesc="Inhouse Asset ID" value="1343814"/>
        </identifiers>
        <balance>295058.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4570448.42000000</valUSD>
        <pctVal>0.395968010127</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Spyre Therapeutics, Inc.</name>
        <lei>52990017AIJPRH3HQH40</lei>
        <title>Spyre Therapeutics, Inc.</title>
        <cusip>00773J202</cusip>
        <identifiers>
          <isin value="US00773J2024"/>
          <other otherDesc="Inhouse Asset ID" value="630868"/>
        </identifiers>
        <balance>220000.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>21632600.00000000</valUSD>
        <pctVal>1.874174432951</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Structure Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Structure Therapeutics, Inc.</title>
        <cusip>86366E106</cusip>
        <identifiers>
          <isin value="US86366E1064"/>
          <other otherDesc="Inhouse Asset ID" value="1236609"/>
        </identifiers>
        <balance>34633.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1663769.32000000</valUSD>
        <pctVal>0.144143280136</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Alto Neuroscience, Inc.</name>
        <lei>N/A</lei>
        <title>Alto Neuroscience, Inc.</title>
        <cusip>02157Q109</cusip>
        <identifiers>
          <isin value="US02157Q1094"/>
          <other otherDesc="Inhouse Asset ID" value="1324662"/>
        </identifiers>
        <balance>165070.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4468444.90000000</valUSD>
        <pctVal>0.387130774231</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Vicore Pharma Holding AB</name>
        <lei>549300KTNBPTZLF01130</lei>
        <title>Vicore Pharma Holding AB</title>
        <cusip>92581R104</cusip>
        <identifiers>
          <isin value="US92581R1041"/>
          <other otherDesc="Inhouse Asset ID" value="1630713"/>
        </identifiers>
        <balance>130759.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1427888.28000000</valUSD>
        <pctVal>0.123707354062</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>SE</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="139080.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Satellos Bioscience, Inc.</name>
        <lei>529900EN243BZ5QC9N39</lei>
        <title>Satellos Bioscience, Inc.</title>
        <cusip>80401L803</cusip>
        <identifiers>
          <isin value="CA80401L8033"/>
          <other otherDesc="Inhouse Asset ID" value="1414384"/>
        </identifiers>
        <balance>96830.00000000</balance>
        <units>NS</units>
        <currencyConditional curCd="CAD" exchangeRt="1.40185000"/>
        <valUSD>967022.15000000</valUSD>
        <pctVal>0.083779489734</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CA</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Vicore Pharma Holding AB</name>
        <lei>549300KTNBPTZLF01130</lei>
        <title>Vicore Pharma Holding AB</title>
        <cusip>N/A</cusip>
        <identifiers>
          <isin value="SE0007577895"/>
          <other otherDesc="Inhouse Asset ID" value="1169744"/>
        </identifiers>
        <balance>8.00000000</balance>
        <units>NS</units>
        <currencyConditional curCd="SEK" exchangeRt="9.52220000"/>
        <valUSD>9.33000000</valUSD>
        <pctVal>0.000000808319</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>SE</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Sartorius Stedim Biotech</name>
        <lei>52990006IVXY7GCSSR39</lei>
        <title>Sartorius Stedim Biotech</title>
        <cusip>N/A</cusip>
        <identifiers>
          <isin value="FR0013154002"/>
          <other otherDesc="Inhouse Asset ID" value="326852"/>
        </identifiers>
        <balance>10100.00000000</balance>
        <units>NS</units>
        <currencyConditional curCd="EUR" exchangeRt="0.86718987"/>
        <valUSD>1952735.01000000</valUSD>
        <pctVal>0.169178278619</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>FR</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>2</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Danish Krone</name>
        <lei>N/A</lei>
        <title>Danish Krone</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="ISO Currency code" value="DKK"/>
        </identifiers>
        <balance>739.99000000</balance>
        <units>OU</units>
        <descOthUnits>Currencies</descOthUnits>
        <currencyConditional curCd="DKK" exchangeRt="6.48200000"/>
        <valUSD>114.16000000</valUSD>
        <pctVal>0.000009890431</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>STIV</assetCat>
        <issuerConditional desc="Foreign currencies" issuerCat="OTHER"/>
        <invCountry>DK</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Franklin Institutional U.S. Government Money Market Fund</name>
        <lei>549300M4TP89K77LG374</lei>
        <title>Franklin Institutional U.S. Government Money Market Fund</title>
        <cusip>457756500</cusip>
        <identifiers>
          <isin value="US4577565009"/>
        </identifiers>
        <balance>36651413.05000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>36651413.05000000</valUSD>
        <pctVal>3.175352998245</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>STIV</assetCat>
        <issuerCat>RF</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <cashCollateralCondition cashCollateralVal="36651413.05000000" isCashCollateral="Y"/>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Alkermes plc</name>
        <lei>N/A</lei>
        <title>Alkermes plc</title>
        <cusip>N/A</cusip>
        <identifiers>
          <isin value="IE00B56GVS15"/>
          <other otherDesc="Inhouse Asset ID" value="502975"/>
        </identifiers>
        <balance>232937.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>11411583.63000000</valUSD>
        <pctVal>0.988660553000</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IE</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>AstraZeneca plc</name>
        <lei>PY6ZZQWO2IZFZC3IOL08</lei>
        <title>AstraZeneca plc</title>
        <cusip>N/A</cusip>
        <identifiers>
          <isin value="GB0009895292"/>
          <other otherDesc="Inhouse Asset ID" value="1225976"/>
        </identifiers>
        <balance>102531.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>17393358.84000000</valUSD>
        <pctVal>1.506901086373</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>GB</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>JATT II Acquisition Corp.</name>
        <lei>N/A</lei>
        <title>JATT II Acquisition Corp.</title>
        <cusip>N/A</cusip>
        <identifiers>
          <isin value="KYG507651092"/>
          <other otherDesc="Inhouse Asset ID" value="1608948"/>
        </identifiers>
        <balance>146753.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1775711.30000000</valUSD>
        <pctVal>0.153841550195</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Jazz Pharmaceuticals plc</name>
        <lei>635400GAUMJCLEZRRV50</lei>
        <title>Jazz Pharmaceuticals plc</title>
        <cusip>N/A</cusip>
        <identifiers>
          <isin value="IE00B4Q5ZN47"/>
          <other otherDesc="Inhouse Asset ID" value="514264"/>
        </identifiers>
        <balance>258371.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>65331691.06000000</valUSD>
        <pctVal>5.660114135431</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IE</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Oculis Holding AG</name>
        <lei>5067005370C2KK324336</lei>
        <title>Oculis Holding AG</title>
        <cusip>N/A</cusip>
        <identifiers>
          <isin value="CH1242303498"/>
          <other otherDesc="Inhouse Asset ID" value="1527895"/>
        </identifiers>
        <balance>314736.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3559664.16000000</valUSD>
        <pctVal>0.308397120945</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CH</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="2061813.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Ascendis Pharma A/S</name>
        <lei>549300B66JN3W3J8GH73</lei>
        <title>Ascendis Pharma A/S</title>
        <cusip>N/A</cusip>
        <identifiers>
          <isin value="DK0060615755"/>
          <other otherDesc="Inhouse Asset ID" value="1608785"/>
        </identifiers>
        <balance>121287.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>29583112.17000000</valUSD>
        <pctVal>2.562979599130</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>DK</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>InflaRx NV</name>
        <lei>391200708PAUDLQ31581</lei>
        <title>InflaRx NV</title>
        <cusip>N/A</cusip>
        <identifiers>
          <isin value="NL0012661870"/>
          <other otherDesc="Inhouse Asset ID" value="817924"/>
        </identifiers>
        <balance>376105.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>639378.50000000</valUSD>
        <pctVal>0.055393565159</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>NL</invCountry>

        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="607240.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Newamsterdam Pharma Co. NV</name>
        <lei>984500B6549TF6E14D36</lei>
        <title>Newamsterdam Pharma Co. NV</title>
        <cusip>N/A</cusip>
        <identifiers>
          <isin value="NL00150012L7"/>
          <other otherDesc="Inhouse Asset ID" value="1366410"/>
        </identifiers>
        <balance>187726.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5216905.54000000</valUSD>
        <pctVal>0.451974842699</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>NL</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>uniQure NV</name>
        <lei>724500RPCTZLFYJZ3S98</lei>
        <title>uniQure NV</title>
        <cusip>N/A</cusip>
        <identifiers>
          <isin value="NL0010696654"/>
          <other otherDesc="Inhouse Asset ID" value="569776"/>
        </identifiers>
        <balance>88716.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3870679.08000000</valUSD>
        <pctVal>0.335342389259</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>NL</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Carmot Therapeutics, Inc.</name>
        <lei>N/A</lei>
        <title>Carmot Therapeutics, Inc., Escrow Account</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Inhouse Asset ID" value="1324740"/>
        </identifiers>
        <balance>83100.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>305253.72000000</valUSD>
        <pctVal>0.026446137662</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>

        <fairValLevel>3</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Lycia LLC</name>
        <lei>N/A</lei>
        <title>Lycia LLC, Series C</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Inhouse Asset ID" value="1349243"/>
        </identifiers>
        <balance>859370.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2071586.15000000</valUSD>
        <pctVal>0.179475134657</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>JP</invCountry>
        <isRestrictedSec>Y</isRestrictedSec>

        <fairValLevel>3</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Candid, Inc.</name>
        <lei>N/A</lei>
        <title>Candid, Inc., Series B</title>
        <cusip>N/A</cusip>
        <identifiers>
          <other otherDesc="Inhouse Asset ID" value="1383625"/>
        </identifiers>
        <balance>1519609.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5563712.52000000</valUSD>
        <pctVal>0.482021012604</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>Y</isRestrictedSec>

        <fairValLevel>3</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
    </invstOrSecs>
    <explntrNotes>
      <explntrNote note="Monthly returns presented in Item B.5(a) have been calculated without deducting any applicable sales loads or redemption fees." noteItem="B.5.a"/>
    </explntrNotes>
    <signature>
      <ncom:dateSigned>2026-08-31</ncom:dateSigned>
      <ncom:nameOfApplicant>Franklin Strategic Series</ncom:nameOfApplicant>
      <ncom:signature>Monica Krogh</ncom:signature>
      <ncom:signerName>Monica Krogh</ncom:signerName>
      <ncom:title>Assistant Treasurer</ncom:title>
    </signature>
  </formData>
  <documents>XXXX</documents>
</edgarSubmission>
